- Home
- IPI vs ADCT Comparison
IPI vs ADCT Comparison
Compare IPI & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPI
- ADCT
- Stock Information
- Founded
- IPI 2000
- ADCT 2011
- Country
- IPI United States
- ADCT Switzerland
- Employees
- IPI N/A
- ADCT N/A
- Industry
- IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- IPI Industrials
- ADCT Health Care
- Exchange
- IPI Nasdaq
- ADCT Nasdaq
- Market Cap
- IPI 356.5M
- ADCT 224.3M
- IPO Year
- IPI 2008
- ADCT 2020
- Fundamental
- Price
- IPI $25.89
- ADCT $1.92
- Analyst Decision
- IPI Sell
- ADCT Strong Buy
- Analyst Count
- IPI 2
- ADCT 5
- Target Price
- IPI $21.00
- ADCT $7.33
- AVG Volume (30 Days)
- IPI 117.4K
- ADCT 471.3K
- Earning Date
- IPI 11-04-2024
- ADCT 11-07-2024
- Dividend Yield
- IPI N/A
- ADCT N/A
- EPS Growth
- IPI N/A
- ADCT N/A
- EPS
- IPI N/A
- ADCT N/A
- Revenue
- IPI $206,359,000.00
- ADCT $70,717,000.00
- Revenue This Year
- IPI N/A
- ADCT $6.38
- Revenue Next Year
- IPI $3.40
- ADCT $11.73
- P/E Ratio
- IPI N/A
- ADCT N/A
- Revenue Growth
- IPI N/A
- ADCT N/A
- 52 Week Low
- IPI $17.52
- ADCT $0.94
- 52 Week High
- IPI $29.75
- ADCT $6.04
- Technical
- Relative Strength Index (RSI)
- IPI 43.87
- ADCT 32.60
- Support Level
- IPI $26.60
- ADCT $1.91
- Resistance Level
- IPI $28.08
- ADCT $2.38
- Average True Range (ATR)
- IPI 1.26
- ADCT 0.21
- MACD
- IPI -0.20
- ADCT -0.01
- Stochastic Oscillator
- IPI 20.26
- ADCT 13.33
About IPI Intrepid Potash Inc
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.